In a marker phase I trial, ApoC1 in tumor tissue is highly expressed in late-stage lung cancer and the over-expression is positively correlated with interleukin-6 (IL-6), a molecule that can foster lung cancer cell proliferation. Here, APOC1 is linked to neoplasm.